Matthijs D. Linssen

1.5k total citations
21 papers, 792 citations indexed

About

Matthijs D. Linssen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Matthijs D. Linssen has authored 21 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Oncology. Recurrent topics in Matthijs D. Linssen's work include Photodynamic Therapy Research Studies (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Matthijs D. Linssen is often cited by papers focused on Photodynamic Therapy Research Studies (6 papers), Nanoplatforms for cancer theranostics (6 papers) and Esophageal Cancer Research and Treatment (5 papers). Matthijs D. Linssen collaborates with scholars based in Netherlands, Germany and China. Matthijs D. Linssen's co-authors include Wouter B. Nagengast, Gooitzen M. van Dam, Annelies Jorritsma‐Smit, Marjory Koller, Vasilis Ntziachristos, Dominic J. Robinson, Steven J. de Jongh, Arend Karrenbeld, Jolien J. Tjalma and Bert van der Vegt and has published in prestigious journals such as Nature Communications, Cancer Research and Gut.

In The Last Decade

Matthijs D. Linssen

20 papers receiving 791 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthijs D. Linssen Netherlands 14 387 272 242 181 131 21 792
Annelies Jorritsma‐Smit Netherlands 13 339 0.9× 241 0.9× 196 0.8× 269 1.5× 122 0.9× 21 810
Anthony B. Morlandt United States 11 328 0.8× 201 0.7× 260 1.1× 141 0.8× 115 0.9× 40 857
Lisa Clemons United States 13 227 0.6× 265 1.0× 294 1.2× 210 1.2× 103 0.8× 17 808
Hajime Imada Japan 16 277 0.7× 375 1.4× 96 0.4× 178 1.0× 44 0.3× 55 827
Adam J. Gomez United States 10 171 0.4× 114 0.4× 94 0.4× 122 0.7× 57 0.4× 22 537
Omoruyi Credit Irabor United States 5 212 0.5× 264 1.0× 100 0.4× 578 3.2× 43 0.3× 9 961
Taek‐Keun Nam South Korea 21 168 0.4× 421 1.5× 657 2.7× 715 4.0× 155 1.2× 101 1.5k
Vincent Noordhoek Hegt Netherlands 18 147 0.4× 153 0.6× 184 0.8× 94 0.5× 36 0.3× 37 884
Paul M. Spring United States 17 218 0.6× 172 0.6× 215 0.9× 260 1.4× 31 0.2× 35 1.0k
Conor McKenna United Kingdom 4 106 0.3× 348 1.3× 138 0.6× 831 4.6× 72 0.5× 5 1.0k

Countries citing papers authored by Matthijs D. Linssen

Since Specialization
Citations

This map shows the geographic impact of Matthijs D. Linssen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthijs D. Linssen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthijs D. Linssen more than expected).

Fields of papers citing papers by Matthijs D. Linssen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthijs D. Linssen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthijs D. Linssen. The network helps show where Matthijs D. Linssen may publish in the future.

Co-authorship network of co-authors of Matthijs D. Linssen

This figure shows the co-authorship network connecting the top 25 collaborators of Matthijs D. Linssen. A scholar is included among the top collaborators of Matthijs D. Linssen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthijs D. Linssen. Matthijs D. Linssen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Linssen, Matthijs D., Michael Dobosz, Dominic J. Robinson, et al.. (2024). Fluorescently labelled vedolizumab to visualise drug distribution and mucosal target cells in inflammatory bowel disease. Gut. 73(9). 1454–1463. 7 indexed citations
3.
Wit, Jaron G. de, Jasper Vonk, Floris J. Voskuil, et al.. (2023). EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial. Nature Communications. 14(1). 4952–4952. 45 indexed citations
4.
Linssen, Matthijs D., et al.. (2022). DOP15 Fluorescent labelled vedolizumab for real-time visualization and quantification of local drug distribution and pharmacodynamics in Inflammatory Bowel Diseases during endoscopy. Journal of Crohn s and Colitis. 16(Supplement_1). i064–i065. 1 indexed citations
5.
Zhao, Xiaojuan, Qingfeng Huang, Marjory Koller, et al.. (2021). Identification and Validation of Esophageal Squamous Cell Carcinoma Targets for Fluorescence Molecular Endoscopy. International Journal of Molecular Sciences. 22(17). 9270–9270. 5 indexed citations
6.
Steinkamp, Pieter J., Jan‐Luuk Hillebrands, Clark J. Zeebregts, et al.. (2021). Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW. Scientific Reports. 11(1). 2899–2899. 8 indexed citations
7.
Vonk, Jasper, Jaron G. de Wit, Floris J. Voskuil, et al.. (2021). Epidermal growth factor receptor targeted fluorescence molecular imaging for postoperative lymph node assessment in patients with oral cancer. Journal of Nuclear Medicine. 63(5). jnumed.121.262530–jnumed.121.262530. 16 indexed citations
8.
Steinkamp, Pieter J., Meifang Li, Matthijs D. Linssen, et al.. (2020). Fluorescence-Guided Visualization of Soft-Tissue Sarcomas by Targeting Vascular Endothelial Growth Factor A: A Phase 1 Single-Center Clinical Trial. Journal of Nuclear Medicine. 62(3). 342–347. 38 indexed citations
9.
Voskuil, Floris J., Steven J. de Jongh, Matthijs D. Linssen, et al.. (2020). Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study. Theranostics. 10(9). 3994–4005. 71 indexed citations
10.
Tjalma, Jolien J., Marjory Koller, Matthijs D. Linssen, et al.. (2019). Quantitative fluorescence endoscopy: an innovative endoscopy approach to evaluate neoadjuvant treatment response in locally advanced rectal cancer. Gut. 69(3). 406–410. 45 indexed citations
11.
Jongh, Steven J. de, Jolien J. Tjalma, Marjory Koller, et al.. (2019). Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer. Journal of Nuclear Medicine. 61(5). 655–661. 44 indexed citations
12.
Linssen, Matthijs D., et al.. (2019). Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW. Journal of Nuclear Medicine. 60(3). 418–423. 26 indexed citations
13.
Hartmans, Elmire, Jolien J. Tjalma, Matthijs D. Linssen, et al.. (2018). Potential Red-Flag Identification of Colorectal Adenomas with Wide-Field Fluorescence Molecular Endoscopy. Theranostics. 8(6). 1458–1467. 51 indexed citations
14.
Koller, Marjory, Siqi Qiu, Matthijs D. Linssen, et al.. (2018). Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers. Nature Communications. 9(1). 3739–3739. 99 indexed citations
16.
Nagengast, Wouter B., Elmire Hartmans, P. Beatriz García-Allende, et al.. (2017). Near-infrared fluorescence molecular endoscopy detects dysplastic oesophageal lesions using topical and systemic tracer of vascular endothelial growth factor A. Gut. 68(1). 7–10. 88 indexed citations
17.
Koller, Marjory, Matthijs D. Linssen, J. de Vries, et al.. (2017). Abstract P4-01-01: Phase II in-human dose escalation study of the optical molecular imaging tracer bevacizumab-800cw for molecular fluorescence guided surgery in primary breast cancer patients. Cancer Research. 77(4_Supplement). P4–1. 3 indexed citations
18.
Thompson, John M., Carly Dillen, Roger V. Ortines, et al.. (2017). Noninvasive optical and nuclear imaging of Staphylococcus-specific infection with a human monoclonal antibody-based probe. Virulence. 9(1). 262–272. 33 indexed citations
19.
Harlaar, Niels J., Marjory Koller, Steven J. de Jongh, et al.. (2016). Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study. ˜The œLancet. Gastroenterology & hepatology. 1(4). 283–290. 145 indexed citations
20.
Scheltinga, Anton G.T. Terwisscha van, Matthijs D. Linssen, Wouter B. Nagengast, et al.. (2016). Development, preclinical safety, formulation, and stability of clinical grade bevacizumab-800CW, a new near infrared fluorescent imaging agent for first in human use. European Journal of Pharmaceutics and Biopharmaceutics. 104. 226–234. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026